Collaboration

Sponsored: FFPE NTRK Fusion RNA Reference Material

United Kingdom   Sponsored

Details

NTRK gene fusions involving either NTRK1, NTRK2, or NTRK3 are oncogenic drivers of multiple adult and pediatric tumor types. NTRK genes can become abnormally fused to other genes resulting in growth signals that can lead to cancer in many organs. These fusions can be detected using a number of methods, including tumor DNA and RNA sequencing and plasma cell-free DNA profiling.

Why join the collaboration:

Receive one 10 µm Seraseq® FFPE NTRK Fusion RNA Reference section, with 15 clinically relevant NTRK fusion genes to use as positive reference standard in molecular assay testing (PCR or NGS) of NTRK gene fusions in adult and pediatric cancer patients

Requirements

To benefit from this opportunity, please ensure that lab assay details in “Assay Management” section reflects the following information for Q2 2021:

· NSCLC disease volumes and corresponding NTRK & RET biomarker volumes and testing methods/assays

· Thyroid Cancer disease volumes and corresponding NTRK & RET biomarker volumes and testing methods/assays

· Breast Cancer disease volumes and corresponding NTRK & BRCA biomarker volumes and testing methods/assays

The information above will help Diaceutics understand how testing is performed in your lab and will enable us to design strategies to support testing and patient treatment.

If your lab does not perform molecular testing for some of the requested biomarkers, please send us a message via “Ask a question”.

Downloads

Downloads available for registered users. Sign up

Sponsored FFPE NTRK Fusion RNA Reference - Jul 2021

(PDF document)

Join this collaboration

Type: Sponsored
Provider: Diaceutics

About the provider

Diaceutics
United Kingdom
Discover and create collaborations on DXRX Marketplace
Work end-to-end on any aspect of diagnostic development and commercialization, either by joining sponsored collaborations or creating your own on the marketplace.